Patent Prosecution · Final Rejection
After Final Rejection
A Final Office Action isn't the end — it's a decision point. Four options: RCE (reopens prosecution), AFCP 2.0 (free examiner interview), Pre-Appeal Brief Conference (quick panel review), and PTAB appeal (challenges the examiner's legal position). Choosing wrong is expensive.
The core strategic question
Is the examiner's rejection wrong as a matter of law, or wrong as a matter of judgment? If legally wrong — appeal. If the rejection has merit but the claims can be amended to address it — RCE. If the error is narrow and immediately fixable — AFCP 2.0 or Pre-Appeal Brief first.
All four options
What to do after a Final Office Action
RCE (Request for Continued Examination)
37 C.F.R. § 1.114Cost
$1,360–$2,720 USPTO fee (small/large) + attorney $2,000–$5,000
Timeline
Reopens prosecution; new FOAM in 18–30 months
Best when
Examiner's position is not entirely unreasonable but a targeted amendment addressing the final rejection's specific concerns would likely overcome it. Applicant needs to make substantive claim amendments and wants fresh examination.
Avoid when
Examiner is being unreasonable and the rejection is legally incorrect — appeal is stronger in that scenario. RCE just resets the clock and costs money if the examiner will reject again on the same grounds.
Key facts
Applicant can file any claims — no restriction to amendments made before final rejection
After RCE, the examiner issues a non-final Office Action (new first OA) — full 3-month response period
Unlimited RCEs are allowed — multiple RCEs are common in complex or pharmaceutical cases
Each RCE adds prosecution history — amendments and arguments made are part of the record
After Final Consideration Pilot 2.0 (AFCP 2.0)
USPTO Pilot Program (administratively offered, not a statutory right)Cost
No additional USPTO fee
Timeline
Examiner responds within 1–3 months
Best when
Amendment is narrow (does not raise new issues), and applicant wants an examiner interview to discuss patentability before deciding between RCE and appeal. The pilot gives the examiner time to consider the amendment and conduct a phone interview.
Avoid when
The claims need substantial broadening or a completely different prosecution strategy. AFCP 2.0 does not give the examiner time for a search — new matter or significantly different claims won't work.
Key facts
Request filed on same day as after-final amendment
Examiner given up to 3 additional hours to consider the amendment + set up interview
If examiner allows claims after the interview — great; if not, applicant still has RCE/appeal options
Does not toll the 3-month statutory period — the response period clock keeps running during AFCP consideration
Pre-Appeal Brief Conference Request
37 C.F.R. § 41.12 (USPTO pilot program)Cost
No additional USPTO fee (a Notice of Appeal $1,600/$800 small entity must be filed)
Timeline
Panel meets within 45 days of request; result in 45–90 days
Best when
Applicant believes there is a clear procedural or substantive error in the final rejection that a 3-person panel (examiner + supervisory examiner + third examiner) would recognize as clearly erroneous on a quick review — e.g., the examiner ignored evidence, made a factual error, or applied the wrong legal standard.
Avoid when
The rejection requires a nuanced argument about claim scope, claim construction, or complex prior art — pre-appeal brief is a 5-page summary, not a place for detailed legal argument.
Key facts
Filed with Notice of Appeal (NTP)
Consists of a 5-page statement of the clear error — no fee
Panel decision: (1) reject pre-appeal conference (go to PTAB appeal); (2) return to examiner for further action; (3) allow claims
Filing the NTP but then winning pre-appeal doesn't change appeal status — can withdraw
Appeal to the PTAB
35 U.S.C. §§ 134, 141–146; 37 C.F.R. §§ 41.30–41.54Cost
Notice of Appeal: $800 small / $1,600 large + appeal brief fee $1,600/$3,200 small/large + attorney $15,000–$40,000
Timeline
12–36 months to decision
Best when
Examiner is legally wrong — improper claim construction, misapplication of KSR/Alice/Graham, failure to establish a prima facie case, ignoring clear claim language. Appeal is the right tool when the examiner's position is legally incorrect, not just when it's unpersuasive.
Avoid when
The PTAB may render a decision that is legally correct but not the one you want — and that decision creates binding prosecution history. If you can get what you want through amendment, that's often faster.
Key facts
After Notice of Appeal, applicant files Appeal Brief (2-month deadline, extendable)
Examiner files Examiner's Answer; applicant may file Reply Brief
PTAB panel of 3 APJs decides; written decision issued
PTAB affirmed: can continue to Federal Circuit or district court (de novo) within 63 days
PTAB reversed: application returned to examiner for allowance or further prosecution
FAQ
After Final Office Action questions
What is a Final Office Action and when does it issue?
A Final Office Action (Final OA, sometimes 'Final Rejection') is an Office Action in which the examiner considers their position final and applicants' options for further prosecution without paying for continued examination are limited. Final OAs typically issue after the applicant has had one substantive response to a non-final Office Action and the examiner continues to maintain a rejection. However, a Final OA can issue earlier in some circumstances: if the claims after the first response present new issues not raised in the first OA; if the examiner determines a final rejection is appropriate based on the record. After a Final OA: the applicant must respond within the 3-month shortened statutory period (extendable by paying monthly fees through 3 extensions, for a maximum of 6 months from the mailing date). The applicant can: (1) amend claims (but new grounds may be rejected as improperly entering the record after final — examiner has discretion to enter or refuse after-final amendments); (2) argue without amendment; (3) request consideration under AFCP 2.0; (4) file a Pre-Appeal Brief Conference request; (5) file a Notice of Appeal; (6) file an RCE. Failing to respond within the extended period causes the application to go abandoned.
What is an RCE and how does it work?
A Request for Continued Examination (RCE) is a filing that converts a Final Office Action into a non-final action by paying a fee to continue prosecution. Under 37 C.F.R. § 1.114, the applicant submits: (1) the RCE fee (currently $1,360 for small entities, $2,720 for large entities); (2) a submission — either an amendment, an argument, or a request for reconsideration — that identifies what the applicant wants the examiner to consider. The RCE's effect: prosecution reopens; the examiner issues a new Office Action (which should be non-final if the examiner is applying a new ground of rejection, or which may be another Final if the same grounds apply to the now-amended claims). After an RCE, applicants get full response periods again (3 months, extendable). Multiple RCEs: an applicant can file as many RCEs as they want — there is no statutory limit, though excessive RCEs can become costly. RCEs are common in complex prosecution (pharmaceutical, biotechnology, software) where multiple rounds are needed to reach allowance. Strategic note: RCEs create prosecution history that becomes relevant to claim scope interpretation and estoppel. Amendments made to overcome rejections in an RCE round are as binding as earlier amendments. Always consider whether an amendment truly overcomes the rejection or just narrowly avoids it — the prosecution history follows the patent.
How does an appeal to the PTAB work?
An ex parte appeal to the Patent Trial and Appeal Board (PTAB) allows an applicant to challenge a final rejection by a panel of three Administrative Patent Judges (APJs) who review the examiner's decision independently. The appeal process: (1) Notice of Appeal (NTP): filed within 3 months of the Final OA mailing date (extendable); fee: $800 small / $1,600 large entity; this starts the appeal clock. (2) Appeal Brief: filed within 2 months of Notice of Appeal (extendable); $1,600 small / $3,200 large entity fee; must include statement of the facts, statement of the rejection, argument for each rejected claim. (3) Examiner's Answer: the examiner responds to the Appeal Brief; may include new grounds of rejection (rare, triggers right to re-brief). (4) Reply Brief: optional; applicant may reply to the Examiner's Answer within 2 months; no additional fee. (5) PTAB Decision: panel of 3 APJs issues a written decision; outcomes: (a) affirmance — rejection upheld; (b) reversal — rejection overturned; (c) new ground of rejection — PTAB may reject on new grounds not used by examiner. After PTAB decision: (a) PTAB affirmed: applicant may appeal to the U.S. Court of Appeals for the Federal Circuit (within 63 days) or file a civil action in district court; (b) PTAB reversed: application returned to examiner, who should allow the claims unless new issues arise; (c) New PTAB ground: applicant may reopen prosecution or maintain appeal. Timeline: typically 12–36 months from Notice of Appeal to PTAB decision. PTAB affirms examiners about 57–65% of the time (varies by art unit and subject matter).
When should an applicant choose RCE vs appeal?
The choice between RCE and appeal depends on whether the examiner's rejection is wrong as a matter of law or whether it can be overcome by amendment: Choose RCE when: (1) The rejection has merit but targeted amendments would address it — if the examiner correctly identified prior art but the claims can be narrowed to avoid it, an RCE with a focused amendment is efficient; (2) The record has evolved and a new submission would present the examiner with information or arguments not previously considered; (3) The applicant needs to re-do their claim strategy substantially — broader, different type of claims, etc.; (4) The technology is complex and iterative prosecution toward allowance is the realistic path. Choose appeal when: (1) The examiner made a legal error — wrong claim construction, failure to establish a prima facie case of obviousness, ignoring claim language, improperly combining references without a rational basis; (2) The rejection is based on factors beyond the claims' scope (improper broadest reasonable interpretation, scope not supported); (3) The examiner is applying an incorrect legal standard (e.g., TSM pre-KSR, wrong Alice analysis); (4) The examiner has consistently rejected reasonable amendments that address the rejection's stated basis — suggesting the rejection will continue in a new round. Warning about appeal: PTAB affirms examiners 57–65% of the time. A failed appeal creates additional prosecution history of an adverse PTAB decision. Factor this into the risk calculation — if the rejection is likely correct on the law, don't waste $20,000+ on an appeal that will lose.
Can an application be abandoned after a Final Office Action and still be revived?
Yes — an abandoned patent application can be revived by petition to the USPTO, but only if the abandonment was unintentional. If an applicant fails to respond to a Final Office Action within the response period (3 months, extendable to 6 months with fees), the application goes abandoned. Revival: (1) The applicant must file a petition for revival under 37 C.F.R. § 1.137(a) (unintentional abandonment); (2) The petition must include a statement that the entire delay from the due date of the response to the filing of the petition was unintentional; (3) The missed response (or RCE, or Notice of Appeal) must be filed with the petition; (4) The revival petition fee must be paid. Timing: there is no statutory time limit on petitions for revival of unintentionally abandoned applications — unlike lapsed patents (which have a 2-year revival window), pending applications can technically be revived years later. In practice, the USPTO scrutinizes petitions for delays that seem inconsistent with an unintentional claim, and very long delays may raise credibility questions. Important consequence: if an abandoned application was published before abandonment (at 18 months from earliest priority date), an intervening publication or third-party patent may have created prior art against the revived application during the abandonment period. Revival is retroactive to the abandonment date in theory, but intervening rights may affect the scope of enforceable claims.